We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
-1.16%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$14.6B
AUM Growth
-$824M
Cap. Flow
-$306M
Cap. Flow %
-2.09%
Top 10 Hldgs %
19.14%
Holding
138
New
3
Increased
38
Reduced
88
Closed
8

Top Buys

Rank Stock Value
1
OKTA icon
Okta
OKTA
+$75.6M
2
TOST icon
Toast
TOST
+$47.6M
3
RGEN icon
Repligen
RGEN
+$46.1M
4
TW icon
Tradeweb Markets
TW
+$41M
5
WDAY icon
Workday
WDAY
+$34M

Sector Composition

Rank Sector Weight
1 Healthcare 22.55%
2 Technology 19.36%
3 Industrials 18.6%
4 Financials 14.82%
5 Consumer Staples 11.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
P
1
Everpure Inc
P
$25B
$391M 2.67%
14,283,375
-240,915
-2% -$6.81M
EG icon
2
Everest Group
EG
$14.9B
$325M 2.22%
1,238,860
+22,175
+2% +$6M
FTV icon
3
Fortive
FTV
$17.7B
$322M 2.2%
7,320,741
-120,153
-2% -$5.62M
AME icon
4
Ametek
AME
$55B
$313M 2.14%
2,760,785
-62,175
-2% -$7.45M
IEX icon
5
IDEX
IEX
$17.3B
$254M 1.73%
1,268,695
-26,295
-2% -$5.32M
WDAY icon
6
Workday
WDAY
$39B
$249M 1.7%
1,634,882
+217,285
+15% +$34M
AAP icon
7
Advance Auto Parts
AAP
$3.39B
$247M 1.69%
1,579,700
-35,500
-2% -$6.49M
EW icon
8
Edwards Lifesciences
EW
$50B
$247M 1.68%
2,985,016
-63,930
-2% -$6.15M
TTC icon
9
Toro Company
TTC
$8.72B
$230M 1.57%
2,663,955
-56,820
-2% -$4.86M
IART icon
10
Integra LifeSciences
IART
$1.33B
$227M 1.55%
5,359,555
-93,260
-2% -$4.78M
GNRC icon
11
Generac Holdings
GNRC
$11.3B
$226M 1.54%
1,268,650
-24,700
-2% -$5.66M
ROK icon
12
Rockwell Automation
ROK
$52.4B
$224M 1.53%
1,040,620
-21,405
-2% -$4.99M
LESL icon
13
Leslie's
LESL
$8.12M
$217M 1.48%
738,411
+15,943
+2% +$4.79M
NDSN icon
14
Nordson
NDSN
$16.4B
$213M 1.45%
1,003,100
-21,195
-2% -$4.75M
PANW icon
15
Palo Alto Networks
PANW
$265B
$213M 1.45%
2,598,236
-61,510
-2% -$5.33M
TW icon
16
Tradeweb Markets
TW
$20.8B
$206M 1.4%
3,643,545
+602,318
+20% +$41M
WAT icon
17
Waters Corp
WAT
$37.3B
$204M 1.39%
757,745
-206,675
-21% -$66M
AJG icon
18
Arthur J. Gallagher & Co
AJG
$65.9B
$194M 1.32%
1,130,140
-670,215
-37% -$119M
PB icon
19
Prosperity Bancshares
PB
$8.97B
$192M 1.31%
2,886,710
-55,745
-2% -$3.98M
CSGP icon
20
CoStar Group
CSGP
$12B
$192M 1.31%
2,757,305
-60,835
-2% -$4.22M
ZS icon
21
Zscaler
ZS
$24B
$191M 1.3%
1,161,501
-18,785
-2% -$3.07M
AKAM icon
22
Akamai
AKAM
$16.5B
$188M 1.28%
2,335,410
+228,555
+11% +$20.8M
FRPT icon
23
Freshpet
FRPT
$2.98B
$186M 1.27%
3,723,089
+52,219
+1% +$2.46M
STE icon
24
Steris
STE
$22.5B
$173M 1.18%
1,041,366
-22,250
-2% -$4.53M
MKC icon
25
McCormick & Company Non-Voting
MKC
$13.7B
$170M 1.16%
2,380,020
-50,575
-2% -$4.24M

Similar funds

Champlain Investment Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Champlain Investment Partners held 138 positions worth $14.6B, down 5.3% from $15.5B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Champlain Investment Partners's Q3 2022 filing shows 3 new, 38 increased, 88 reduced and 8 closed positions. Its largest new stake was Toast: 2,747,085 shares worth $45.9M. The largest sale was Arthur J. Gallagher & Co, an estimated $119M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.

  • Champlain Investment Partners's largest Q3 2022 buy was Toast: 2,747,085 shares worth $45.9M.
  • Champlain Investment Partners added most to Okta in Q3 2022, an estimated $75.6M increase.
  • Champlain Investment Partners's biggest Q3 2022 reduction was Arthur J. Gallagher & Co, cutting an estimated $119M.
  • Champlain Investment Partners fully exited ZENDESK INC in Q3 2022, selling an estimated $95.8M.
  • Champlain Investment Partners's ten largest holdings make up 19% of its $14.6B portfolio in Q3 2022.
  • Champlain Investment Partners opened 3 new positions and closed 8 in Q3 2022.
  • Champlain Investment Partners's portfolio value fell 5.3% quarter-over-quarter to $14.6B.

Based on Champlain Investment Partners's 13F filing for Q3 2022, filed 14 Nov 2022.